Market Research Report
LAMEA Electrocardiograph (ECG) Market Analysis (2017-2023)
|Published by||KBV Research||Product code||616202|
|Published||Content info||80 Pages
|LAMEA Electrocardiograph (ECG) Market Analysis (2017-2023)|
|Published: February 28, 2018||Content info: 80 Pages||
The LAMEA Electrocardiograph (ECG) Market would witness market growth of 7.0% CAGR during the forecast period (2017 - 2023). Electrocardiography (ECG) is a non-invasive medical test used in recording electrical activity of the heartbeat over a time span. Each heartbeat produces an electrical impulse, which is recorded with the help of electrodes. The electrodes detect smallest electrical changes in the skin which is caused due to heart muscle depolarizing during each heartbeat. An ECG is used by cardiologists to determine if the electrical activity is normal or slow, and fast or irregular.
Technological advancements of ECG devices such as their portability, handheld, novel electrodes & sensors, and smart phone integration would contribute to the market growth. Additionally, growing cases of cardiovascular diseases along with significantly growing older population further adds to the market growth. Moreover, emergence of novel ECG devices such as handheld ECG devices and ECG devices integrated with artificial intelligence systems would add to the growth of the market.
Based on product, the market report segments the market into Resting ECG, Stress ECG, and Holter Monitors. Holter Monitors further sub segmented into Portable ECG Systems and Wireless ECG Systems. The Lead Type covered under the report includes Single Lead ECG, 3-6 Lead ECG, and 12 Lead ECG. The end User covered under the report is Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), and Others. The report also covers country wise segmentation of Electrocardiograph (ECG) market. The countries included in the report are Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the LAMEA Electrocardiograph (ECG) Market. Key companies profiled in the report include Compumed, Bionet, Mindray Medical International Limited, General Electric (GE) (GE Healthcare), Koninklijke Philips N.V (Philips Healthcare), Schiller AG, Welch Allyn, Nihon Kohden Corporation, Medtronic, and Opto Circuits Limited.